Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
Public ClinicalTrials.gov record NCT00083928. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Å6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether injections of Å6 are effective in treating ovarian cancer patients who have completed first-line therapy and currently have no detectable cancer but have experienced a doubling of CA 125 levels.
Study identification
- NCT ID
- NCT00083928
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2004
- Primary completion
- Jan 31, 2006
- Completion
- Nov 30, 2006
- Last update posted
- Jan 23, 2013
2004 – 2006
United States locations
- U.S. sites
- 24
- U.S. states
- 18
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama, Birmingham | Birmingham | Alabama | 35233 | — |
| Desert Oasis Cancer Center | Casa Grande | Arizona | 85222 | — |
| California Oncology of the Central Valley | Fresno | California | 93710 | — |
| USC Keck School of Medicine Women's and Childrens Hospital | Los Angeles | California | 90033 | — |
| University of California Irvine Medical Center | Orange | California | 92668 | — |
| UC Davis Health System | Sacramento | California | 95817 | — |
| Scripps Cancer Center | San Diego | California | 92121 | — |
| University of Colorado Cancer Center | Aurora | Colorado | 80010 | — |
| Florida Hospital Cancer Institute | Orlando | Florida | 32804 | — |
| Medical College of Georgia Dept. of OB/GYN | Saint Agusta | Georgia | 30912 | — |
| Tripler Army Medical Center | Honolulu | Hawaii | 96859 | — |
| Gynecologic Oncology | Hinsdale | Illinois | 60521 | — |
| St. Vincent Gyn-Onc | Indianapolis | Indiana | 46260 | — |
| Northern Indiana Cancer Research Consortium | South Bend | Indiana | 46617 | — |
| University of Louisville JG Brown Cancer Center | Louisville | Kentucky | 40202 | — |
| Hematology & Oncology Specialists | New Orleans | Louisiana | 70115 | — |
| Barnes Jewish Hospital | St Louis | Missouri | 63110 | — |
| Gabrail Cancer Center | Canton | Ohio | 44718 | — |
| OSU College of Medicine | Columbus | Ohio | 43210 | — |
| University of Oklahoma College of Medicine | Oklahoma City | Oklahoma | 73190 | — |
| Gynecologic-Oncology Research and Development, LLC | Greenville | South Carolina | 29601 | — |
| Chattanooga GYN Oncology | Chattanooga | Tennessee | 37403 | — |
| Brooke Army Medical Center | Fort Sam Houston | Texas | 78234 | — |
| Carilion Gynecologic Oncology Associates | Roanoke | Virginia | 24014 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00083928, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 23, 2013 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00083928 live on ClinicalTrials.gov.